RxDoctor Payments Data

Sunita Gupta, MD

Family Medicine · Gilbert, AZNPI 1750319265

Payments from drug & device makers

$2,709in general payments, 2019–2025

Across 116 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$718
  • Abbott$337
  • AstraZeneca$234
  • Teleflex LLC$166
  • Stryker$143
  • Boehringer Ingelheim$88
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$2,69599%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,709 in reported general payments places this provider in the 80th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$520,813
Medicare patients
449
Services billed
5,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium307$4,881
Levothyroxine Sodium417$4,022
SymbicortBudesonide/Formoterol Fumarate12$3,854
Losartan Potassium349$3,473
Atorvastatin Calcium340$2,982
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,842
Amlodipine Besylate365$1,720
Duloxetine Hcl106$1,433
Gabapentin113$1,385
Pravastatin Sodium98$1,316
SynthroidLevothyroxine Sodium22$1,231
Metformin Hcl164$890
Pantoprazole Sodium82$874
Lisinopril140$863
Omeprazole109$835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaSymbicort$234$3,85412 claims
AbbVieSynthroid$718$1,23122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →